Skip to content

Nutritional Supplements for Exercise Recovery

Evaluation of Nutritional Supplements for Exercise Recovery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03510806
Enrollment
10
Registered
2018-04-27
Start date
2018-03-20
Completion date
2018-07-01
Last updated
2019-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-exercise Muscle Soreness

Brief summary

This study will examine the effects of nutritional supplement on post-exercise muscle soreness as well as recovery of muscle strength and function.

Interventions

DIETARY_SUPPLEMENTSupplement

dietary supplement contain protein from milk and fruit extract

OTHERPlacebo

color, taste, and calorie-matched placebo

Sponsors

Catherine Mikus
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Ability to consume supplement * Willing to adhere to the study intervention regimen * Willing to abstain from analgesics for duration of the study * Agreement to adhere to Lifestyle Considerations

Exclusion criteria

* Current use of NSAIDs * Use of other nutritional or herbal supplements (e.g., protein powders, tart cherry juice, BCAAs, Vitamin D, probiotics, etc.) that have been shown to effect primary or secondary outcomes * Presence of chronic diseases, including, but not limited to, cancer, HIV, hepatitis, cardiovascular, metabolic, and orthopedic conditions * Weight \> 350 pounds * Pregnancy or lactation * Known food allergies or sensitivities or dietary restrictions * Habitual consumption of \> 2 alcoholic drinks per day * Febrile illness or antibiotic use within 1 month prior to baseline testing * Treatment with another investigational drug or other intervention within 1 month * Current smoker or tobacco use within 1 month * Any condition(s) or diagnosis, both physical or psychological, that, in the opinion of the principal investigator or study physician, precludes participation and/or ability to consent * Any other factor that, in the opinion of the principal investigator or study physician, would cause harm or increased risk to the participant or close contacts, or preclude the participant's full adherence with or completion of the study

Design outcomes

Primary

MeasureTime frameDescription
post-exercise muscle soreness7 daysVAS score

Secondary

MeasureTime frameDescription
post-exercise muscle strength7 dayscountermovement jump performance
post-exercise muscle function7 daysrepetitive countermovement jumps
satiety4-5 hoursVAS scores
sleep quality15 dayssleep metrics, Fitbit

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026